A 32-year-old woman with systemic lupus erythematosus is started on procainamide for atrial fibrillation. After 6 weeks of therapy, she develops fever, arthralgia, and a positive antinuclear antibody (ANA) titer that was previously negative. Her procainamide level is therapeutic. Which classification of adverse drug reaction best describes this presentation?